Top Markets
Coin of the day
NanoVibronix, Inc. NanoVibronix, Inc.

NanoVibronix, Inc.

NAOV
Clasificación en acciones #37687
NanoVibronix, Inc., operating through its subsidiary NanoVibronix Ltd.,... NanoVibronix, Inc., operating through its subsidiary NanoVibronix Ltd., develops and commercializes innovative, non-invasive devices that stimulate biological responses for therapeutic purposes. Their core focus areas include mitigating biofilm formation, accelerating wound repair, and alleviating pain. Key among their product line is UroShield, an ultrasound-based solution engineered to deter bacterial colonization and biofilm development in urinary catheters, thereby boosting antibiotic efficacy and reducing associated patient discomfort. They also offer PainShield and WoundShield, both patch-based therapeutic ultrasound technologies. PainShield targets relief from pain, muscle spasms, and joint contractures, while WoundShield is designed to foster tissue regeneration and promote healing in wounds. The company distributes these products directly to consumers and via extensive distributor networks spanning the United States, Israel, Europe, India, and numerous other international regions. Founded in 2003, NanoVibronix, Inc. maintains its corporate headquarters in Elmsford, New York.
Precio por acción
$1.90
Última sincronización: 2026-03-11
Capitalización bursátil
$1.51M
Cambio (1 día)
-41.54%
Cambio (1 año)
-67.58%
País
US
Comercio NanoVibronix, Inc. (NAOV)

Categoría

Historial de rendimiento por dividendo de NanoVibronix, Inc. (NAOV)
Rendimiento por dividendo (TTM) de NanoVibronix, Inc. (símbolo bursátil: NAOV) al 2026: 0
Rendimiento promedio por dividendo de los últimos 5 años: 0.00%
Historial de rendimiento por dividendo de NanoVibronix, Inc. (NAOV) desde 2026 hasta 2026
Rendimiento por dividendo al final de cada año (TTM)
Año Rendimiento por dividendo Cambiar
Not enough data for the provided dates.
Rendimientos por dividendo (TTM) de empresas similares o competidoras